Cynthia S Samary Selected Research

Pneumonia (Pneumonitis)

1/2021	Impact of different frequencies of controlled breath and pressure-support levels during biphasic positive airway pressure ventilation on the lung and diaphragm in experimental mild acute respiratory distress syndrome.
1/2021	Impact of positive biphasic pressure during low and high inspiratory efforts in Pseudomonas aeruginosa-induced pneumonia.
1/2019	Effects of Obesity on Pulmonary Inflammation and Remodeling in Experimental Moderate Acute Lung Injury.
1/2017	Sevoflurane, Compared With Isoflurane, Minimizes Lung Damage in Pulmonary but Not in Extrapulmonary Acute Respiratory Distress Syndrome in Rats.
1/2017	Effects of pressure support and pressure-controlled ventilation on lung damage in a model of mild extrapulmonary acute lung injury with intra-abdominal hypertension.
4/2016	The Effects of Short-Term Propofol and Dexmedetomidine on Lung Mechanics, Histology, and Biological Markers in Experimental Obesity.
4/2016	Fast Versus Slow Recruitment Maneuver at Different Degrees of Acute Lung Inflammation Induced by Experimental Sepsis.
1/2015	Modulation of stress versus time product during mechanical ventilation influences inflammation as well as alveolar epithelial and endothelial response in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cynthia S Samary Research Topics

Disease

8	Pneumonia (Pneumonitis) 01/2021 - 01/2015
7	Inflammation (Inflammations) 11/2023 - 01/2015
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 07/2016
3	Stroke (Strokes) 11/2023 - 10/2018
3	Ischemic Stroke 11/2023 - 10/2018
3	Edema (Dropsy) 01/2021 - 01/2015
2	Obesity 01/2019 - 04/2016
2	Lung Injury 10/2017 - 01/2010
2	Sepsis (Septicemia) 04/2016 - 04/2012
1	Atrophy 01/2021
1	Muscular Atrophy (Muscle Atrophy) 01/2021
1	Acute Lung Injury 01/2019
1	Emphysema 01/2017
1	Pulmonary Atelectasis 04/2016
1	Body Weight (Weight, Body) 04/2016
1	Ventilator-Induced Lung Injury 08/2015
1	Hypovolemia 01/2010
1	Pulmonary Edema 01/2010

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2015
5	Messenger RNA (mRNA)IBA 10/2018 - 01/2010
4	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2023 - 01/2010
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 01/2010
4	Interleukin-6 (Interleukin 6)IBA 10/2018 - 01/2015
3	SodiumIBA 11/2023 - 04/2016
3	Dexmedetomidine FDA Link 11/2023 - 04/2016
3	Thiopental (Pentothal)FDA Link 11/2023 - 04/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 10/2018
2	Propofol (Diprivan)FDA LinkGeneric 11/2021 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
2	AmphiregulinIBA 01/2021 - 01/2020
2	salicylhydroxamic acid (SHAM)IBA 10/2018 - 04/2012
2	InterleukinsIBA 10/2018 - 01/2010
2	Collagen Type III (Type III Collagen)IBA 01/2017 - 01/2010
2	LipopolysaccharidesIBA 07/2016 - 01/2015
2	Oxygen (Dioxygen)IBA 04/2016 - 04/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2023
1	Neuroprotective AgentsIBA 11/2023
1	E-SelectinIBA 11/2023
1	Ketamine FDA LinkGeneric 11/2023
1	OxidesIBA 11/2023
1	EsketamineIBA 11/2023
1	CXCR ReceptorsIBA 11/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2023
1	ArginaseIBA 11/2023
1	Hypnotics and Sedatives (Sedatives)IBA 11/2021
1	EndotoxinsIBA 01/2019
1	Pancreatic Elastase (Elastase)IBA 01/2017
1	Isoflurane FDA LinkGeneric 01/2017
1	Surface-Active Agents (Surfactants)IBA 01/2017
1	IgA receptor (protein B)IBA 01/2017
1	Anesthetics (Anesthetic Agents)IBA 01/2017
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2017
1	Cadherins (E-Cadherin)IBA 07/2016
1	Angiopoietin-1IBA 07/2016
1	Angiopoietin-2IBA 07/2016
1	AngiopoietinsIBA 04/2016
1	EnzymesIBA 04/2016
1	Receptor for Advanced Glycation End ProductsIBA 01/2015
1	Colloids (Colloid)IBA 01/2010
1	GasesIBA 01/2010
1	Caspase 3 (Caspase-3)IBA 01/2010

Therapy/Procedure

4	Artificial Respiration (Mechanical Ventilation) 10/2017 - 01/2015
4	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 04/2016 - 01/2010
2	Continuous Positive Airway Pressure 01/2021 - 01/2021
2	Punctures 04/2016 - 04/2012
2	Ligation 04/2016 - 04/2012